Drug test for determining prothrombin time (PT) and quantifying fibrinogen - Vietnam Registration 2300636ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Drug test for determining prothrombin time (PT) and quantifying fibrinogen in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2300636ĐKLH/BYT-HTTB and manufactured by Instrumentation Laboratory Company.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2300636ĐKLH/BYT-HTTB
17004867/ĐKLH-BYT-TB-CT
HemosIL ReadiPlasTin
0020301400
Technical Details
HemosIL ReadiPlasTin is a thromboplastin test, used in in vitro diagnosis, based on recombinant human tissue factor, and is used for the determination of prothrombin time (Prothrombin Time - PT) and quantification of fibrinogen in human plasma samples (anticoagulated with citrate), performed on the ACL TOP Family and ACL TOP Family 50 Series blood coagulation analyzers. The test is used to evaluate the extrinsic coagulation pathway and to monitor oral anticoagulant therapy with Vitamin K antagonists.
Dates and Status
Jun 20, 2023